Neurogene Inc.
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome (NCT05898620) | Neurogene Inc. | 2023-06-13 |
| Gene Therapy Study for Children With CLN5 Batten Disease (NCT05228145) | Neurogene Inc. | 2022-01-31 |
| NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory Cancer (NCT04659629) | Neurogene Inc. | 2021-04-26 |
| A Natural History Study of Charcot-Marie-Tooth 4J (CMT4J) (NCT03810508) | Neurogene Inc. | 2019-07-18 |
| A Natural History Study of Aspartylglucosaminuria (NCT03853876) | Neurogene Inc. | 2019-04-18 |
| A Natural History Study of Neuronal Ceroid Lipofuscinosis Type 5 (CLN5) (NCT03822650) | Neurogene Inc. | 2019-03-13 |
Track Neurogene Inc. automatically
Every clearance here is in the API, with alerts when new ones post.